Clinical Trial: BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Bronchiolitis Obliterans Syndrome
Study Type: INTERVENTIONAL
Official Title: An Open-Label, Phase 2 Study to Evaluate the Activity of Belumosudil in Subjects With New Onset and Incipient Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell Transplantation
Brief Summary:
The goal of this research study is to test the efficacy of a novel immunosuppressive agent, belumosudil, in allogeneic hematopoietic stem cell transplant (HSCT) recipients who have been newly diagnosed or have developing (early stage) bronchiolitis obliterans syndrome (BOS).The name of the study drugs involved in this study are:Belumosudil (an immunotherapy)Fluticasone (an intranasal corticosteroid)Azithromycin (an antibiotic)Montelukast (a leukotriene receptor antagonist)Prednisone (a corticosteroid)
Read more